1) Trial enrollees were likely partial/non responders to MMF at baseline (NIN had clean slate) 2) Unblinding from diarrhea from NIN, likely tilts toward NIN d/t PLBO effect 3) MMF-PLBO may have had dx longer than NIN-PLBO, missed critical early window to affect progression?